Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study

Trial Profile

Treatment of Portal, Mesenteric, and Splenic Vein Thrombosis With Rivaroxaban. A Pilot, Prospective Cohort Study

Recruiting
Phase of Trial: Phase III

Latest Information Update: 11 May 2017

At a glance

  • Drugs Rivaroxaban (Primary)
  • Indications Thrombosis
  • Focus Therapeutic Use
  • Acronyms RIDTS
  • Most Recent Events

    • 01 May 2017 Planned End Date changed from 1 Dec 2018 to 1 Dec 2019.
    • 01 May 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Jun 2019.
    • 11 Dec 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top